Emory University Ascendis Pharma A/S Transaction History

Emory University

  • $34.7 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$95.8 - $118.9 $1.76 Million - $2.18 Million
-18,334 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$107.11 - $132.09 $1.51 Million - $1.87 Million
-14,143 Reduced 43.55%
18,334 $2.11 Million
Q1 2019

May 09, 2019
SELL
$62.15 - $129.99 $418,891 - $876,132
-6,740 Reduced 17.19%
32,477 $3.82 Million
Q4 2018

Feb 12, 2019
BUY
$55.16 - $69.67 $2.16 Million - $2.73 Million
39,217 New
39,217 $2.46 Million

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Emory University Portfolio

Follow Emory University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

News

Stay updated on Emory University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email